Elanco CFO granted deferred stock units at $23.97

Elanco Animal Health Inc (ELAN) reported that EVP and CFO Robert M. VanHimbergen acquired 8.2194 Deferred Stock Units on 2026-08-21 as a grant/award.

Rhea-AI Filing Summary

Elanco Animal Health Inc (ELAN) reported that EVP and CFO Robert M. VanHimbergen acquired 8.2194 Deferred Stock Units on 2026-08-21 as a grant/award. Each unit corresponds to one share of common stock or the cash equivalent and will settle in cash or shares after employment ends or in a specified future year. Following this award, he directly holds 141.8242 Deferred Stock Units.

Insider Trade Summary

Grant/Award: 8.2194 shares

Grant/Award 1 txn

Insider VanHimbergen Robert M

Role EVP and CFO

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units F1, F2	8.2194	$23.97	$197.02

Holdings After Transaction: Deferred Stock Units — 141.8242 contracts (Direct)

Footnotes (2)

1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Deferred Stock Units granted: 8.2194 units Filed value per Deferred Stock Unit: $23.9700 per unit Deferred Stock Units held after transaction: 141.8242 units +1 more

4 metrics

Deferred Stock Units granted 8.2194 units Grant to EVP and CFO on 2026-08-21

Filed value per Deferred Stock Unit $23.9700 per unit Value reported for the 2026-08-21 grant

Deferred Stock Units held after transaction 141.8242 units Direct holdings of EVP and CFO after the award

Underlying common stock per unit 1 share per unit Each Deferred Stock Unit represents one share or cash equivalent

Key Terms

Deferred Stock Units, Executive Deferral and Stock Match Plan, cash equivalent

3 terms

Deferred Stock Units financial

"Each deferred stock unit represents the right to receive one share"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Executive Deferral and Stock Match Plan financial

"in accordance with Executive Deferral and Stock Match Plan"

cash equivalent financial

"receive one share of Company common stock or the cash equivalent"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ELAN report for Robert M. VanHimbergen?

Elanco reported that EVP and CFO Robert M. VanHimbergen received a grant of 8.2194 Deferred Stock Units on 2026-08-21, each tied to one share of common stock or its cash equivalent, increasing his directly held Deferred Stock Units to 141.8242.

What type of security did the ELAN executive receive in this Form 4?

Robert M. VanHimbergen received Deferred Stock Units, each representing the right to receive one share of Elanco common stock or the cash equivalent, with settlement in cash or shares after termination of employment or in a specified future year.

What was the reference price for the Deferred Stock Units granted to the ELAN CFO?

The 8.2194 Deferred Stock Units granted to the Elanco CFO on 2026-08-21 carried a filed value of $23.97 per unit, as reported in the Form 4 transaction data.

How many Deferred Stock Units does the ELAN CFO hold after this transaction?

After the 2026-08-21 award, EVP and CFO Robert M. VanHimbergen directly holds 141.8242 Deferred Stock Units, each linked to one share of Elanco common stock or the cash equivalent, subject to the plan’s settlement rules.

When will the ELAN Deferred Stock Units reported in this Form 4 settle?

The reported Deferred Stock Units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, in accordance with the company’s Executive Deferral and Stock Match Plan.

Were the ELAN insider transactions made under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not affirmed, and no footnote states that this award was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 04:42 PM EDT Accepted by SEC EDGAR 08/25/2026 - 04:42 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VanHimbergen Robert M

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	08/21/2026		A		8.2194		(2)	(2)	Common Stock	8.2194	$23.97	141.8242	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen	08/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)